Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	AKB-6548 240 mg	18
Overall Study	STARTED	AKB-6548 370 mg	18
Overall Study	STARTED	AKB-6548 500 mg	17
Overall Study	STARTED	AKB-6548 630 mg	19
Overall Study	STARTED	Placebo	19
Overall Study	COMPLETED	AKB-6548 240 mg	16
Overall Study	COMPLETED	AKB-6548 370 mg	15
Overall Study	COMPLETED	AKB-6548 500 mg	17
Overall Study	COMPLETED	AKB-6548 630 mg	18
Overall Study	COMPLETED	Placebo	18
Overall Study	NOT COMPLETED	AKB-6548 240 mg	2
Overall Study	NOT COMPLETED	AKB-6548 370 mg	3
Overall Study	NOT COMPLETED	AKB-6548 500 mg	0
Overall Study	NOT COMPLETED	AKB-6548 630 mg	1
Overall Study	NOT COMPLETED	Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01381094/flow